Abstract

Studying protease/peptide inhibitor interactions is a useful tool for understanding molecular recognition in general and is particularly relevant for the rational design of inhibitors with therapeutic potential. An inhibitory peptide (PMTLEYR) derived from the third domain of turkey ovomucoid inhibitor and optimized for specific porcine pancreatic elastase inhibition was introduced into an inhibitor scaffold to increase the proteolytic stability of the peptide. The trypsin-specific squash inhibitor EETI II from Ecballium elaterium was chosen as the scaffold. The resulting hybrid inhibitor HEI-TOE I (hybrid inhibitor from E. elaterium and the optimized binding loop of the third domain of turkey ovomucoid inhibitor) shows a specificity and affinity to porcine pancreatic elastase similar to the free inhibitory peptide but with significantly higher proteolytic stability. Isothermal titration calorimetry revealed that elastase binding of HEI-TOE I occurs with a small unfavorable positive enthalpy contribution, a large favorable positive entropy change, and a large negative heat capacity change. In addition, the inhibitory peptide and the hybrid inhibitor HEI-TOE I protected endothelial cells against degradation following treatment with porcine pancreatic elastase.

Highlights

  • Proteases can play a decisive role as indirect virulence factors promoting infection by viruses, bacteria, or parasites

  • Inappropriate or altered host protease activities are involved in many diseases, such as cancer, blood clotting, Alzheimer’s disease, rheumatoid arthritis, arteriosclerosis, and pulmonary emphysema

  • Protease inhibitors have a huge potential as therapeutic tools for treating any number of diverse diseases [1]

Read more

Summary

Introduction

Proteases can play a decisive role as indirect virulence factors promoting infection by viruses, bacteria, or parasites. The effects of the optimized inhibitory peptide PMTLEYR and of one of the hybrid squash inhibitors (HEI-TOE I) on elastase-treated human endothelial cells were compared.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.